TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
University of Alabama at Birmingham
City of Hope Medical Center
Washington University School of Medicine
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Chicago
City of Hope Medical Center
Mayo Clinic
University of Virginia
Icahn School of Medicine at Mount Sinai
Vanderbilt-Ingram Cancer Center
Fox Chase Cancer Center
City of Hope Medical Center
OHSU Knight Cancer Institute
Dartmouth-Hitchcock Medical Center
Herlev Hospital
Icahn School of Medicine at Mount Sinai
Roswell Park Cancer Institute
University of Rochester
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Mayo Clinic
University of Pittsburgh
Northwestern University
Stanford University
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
University of Louisville
Washington University School of Medicine
Yale University
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Indiana University
Indiana University
Duke University
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Northwestern University
NYU Langone Health
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Arizona